Search - tctmd.com

Displaying 61 - 80 of 80

Sort: Relevancy | Date

News Conference News ACC 2013

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

L.A. McKeown

March 08, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

Presentation TCT 2013

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Presenter: Akiko Maehara, Gary Mintz, Sorin Brener, Jan-Henk Dambrink, Magdi El-Omar, Anthony Gershlick, Martin Fahy, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

News Daily News

STEMI Patients with Preinfarction Angina Show Fewer Signs of Myocardial Damage

Caitlin E. Cox

January 31, 2013

Presentation Cell Therapy 2013

Microvascular Obstruction, Infarct Size, and LV Remodeling

Presenter: Andreas M. Zeiher

January 23, 2013

News Daily News

MUSTELA Published: Thrombectomy Shows Mixed Results in STEMI

December 26, 2012

News Conference News TCT 2012

AIDA-STEMI Substudy Confirms Original Findings

October 26, 2012

News Industry News

Study Confirms that Intracoronary and Intravenous Use of ABCIXIMAB During Angioplasty Yield Similar Results

October 25, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Conference News TCT 2012

REOPEN-AMI: Addition of Adenosine to Thrombus Aspiration Enhances PCI Outcomes

October 24, 2012

News Conference News TCT 2012

Mesh-Covered Stent Shines in MASTER Trial

October 24, 2012

Presentation TCT 2012

TCT-59. Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

Presenter: Akiko Maehara

October 23, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Conference News

MUSTELA: Thrombectomy Use Not Associated with Smaller Infarcts at 1 Year

November 09, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Daily News

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

Jason Kahn

June 20, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

Caitlin E. Cox

May 19, 2011

Advertisement

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

STEMI Patients with Preinfarction Angina Show Fewer Signs of Myocardial Damage

Microvascular Obstruction, Infarct Size, and LV Remodeling

MUSTELA Published: Thrombectomy Shows Mixed Results in STEMI

AIDA-STEMI Substudy Confirms Original Findings

Study Confirms that Intracoronary and Intravenous Use of ABCIXIMAB During Angioplasty Yield Similar Results

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

REOPEN-AMI: Addition of Adenosine to Thrombus Aspiration Enhances PCI Outcomes

Mesh-Covered Stent Shines in MASTER Trial

TCT-59. Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy

STEMI Patient Population Evolves Over 15 Years

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

MUSTELA: Thrombectomy Use Not Associated with Smaller Infarcts at 1 Year

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content